Article info

Download PDFPDF

OTH-12 Efficacy and safety of vedolizumab subcutaneous formulation for ulcerative colitis: results of the visible trial
Free

Authors

Citation

Sandborn W, Baert F, Danese S, et al
OTH-12 Efficacy and safety of vedolizumab subcutaneous formulation for ulcerative colitis: results of the visible trial

Publication history

  • First published June 1, 2019.
Online issue publication 
June 16, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.